1. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
    Linda M. Liau et al, 2023, JAMA Oncology CrossRef
  2. Results From the CheckMate 143 Clinical Trial
    Yagmur Muftuoglu et al, 2020, JAMA Oncology CrossRef
  3. Optimizing the role of immunotherapy for the treatment of glioblastoma
    Rita Cascão et al, 2023, New Insights Into Glioblastoma CrossRef
  4. Progress in research and development of temozolomide brain-targeted preparations: a review
    Jiefen Yang et al, 2023, Journal of Drug Targeting CrossRef
  5. Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma
    R. J. Head et al, 2017, Cancer Biology & Therapy CrossRef
  6. Immunotherapy for Brain Tumors
    John H. Sampson et al, 2017, Journal of Clinical Oncology CrossRef
  7. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
    Manendra Singh Tomar et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  8. Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives
    Pasquale Persico et al, 2021, Journal of Clinical Medicine CrossRef
  9. Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early
    Mariangela Morelli et al, 2022, Frontiers in Oncology CrossRef
  10. Effects of Some Growth Factors and Cytokines on the Expression of the Repair Enzyme MGMT and Protein MARP in Human Cells In Vitro
    Kateryna Kotsarenko et al, 2018, Biochemical Genetics CrossRef
  11. Incidence of biomarkers in high-grade gliomas and their impact on survival in a diverse SouthEast Asian cohort - a population-based study
    Samantha Ya Lyn Ang et al, 2020, BMC Cancer CrossRef
  12. Characterization of gliomas: from morphology to molecules
    Sean P. Ferris et al, 2017, Virchows Archiv CrossRef
  13. Prognostic value of test(s) for O6-methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
    null null et al, 2021, Cochrane Database of Systematic Reviews CrossRef
  14. RNA-SSNV: A Reliable Somatic Single Nucleotide Variant Identification Framework for Bulk RNA-Seq Data
    Qihan Long et al, 2022, Frontiers in Genetics CrossRef